Lyell Immunopharma (NASDAQ:LYEL) Receives Nasdaq Notification Regarding Minimum Bid Price Requirements
Lyell Immunopharma, Inc. (NASDAQ: LYEL) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission that it has received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC. The notice, received on January 23, 2025, informed the company that for the past 33 consecutive business days, the bid […]
More Stories
Canada’s Dollar-for-Dollar Tariff Response Exposes a Trade Relationship America Should Have Reexamined Decades Ago
By Stephen Zogopoulos, USNN World News Canada has now formally answered Washington’s latest tariffs with what it calls a “dollar-for-dollar,...
South Carolinians Go to Polls for Key Republican Senate Primary
By Joseph Lord CHARLESTON, S.C.—South Carolina voters will head to the polls today to make their pick in a runoff...
Iran Vows to Retaliate After US Rolls Out ‘Economic D-Day’ Sanctions
By Owen Evans Iran has promised to retaliate against the United States after Washington rolled out an “economic D-Day” sanctions...
ICE Arrests More Than 1,300 Illegal Immigrants in Virginia, Maryland in 2-Week Operation
By Aldra Fredly Immigration and Customs Enforcement (ICE) arrested more than 1,300 illegal immigrants during a two-week operation in Virginia...
Bessent Warns China, Others Not to Test US Resolve on Iran Sanctions
By Andrew Moran and Emel Akan Bessent, at an Aug. 24 news conference, unveiled the contours of the administration’s sweeping...
Gold Prices Surge to Highest Level in Over 3 Months
By Naveen Athrappully Gold prices are trading at their highest level in more than three months on Monday, amid continued...